Shuttle Pharmaceuticals (SHPH) Competitors $3.49 +0.04 (+1.16%) As of 10:35 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. IMNN, NRSN, PRPH, NXTC, SNGX, FLGC, LGVN, BFRG, TXMD, and LPTXShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Imunon (IMNN), NeuroSense Therapeutics (NRSN), ProPhase Labs (PRPH), NextCure (NXTC), Soligenix (SNGX), Flora Growth (FLGC), Longeveron (LGVN), Bullfrog AI (BFRG), TherapeuticsMD (TXMD), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors Imunon NeuroSense Therapeutics ProPhase Labs NextCure Soligenix Flora Growth Longeveron Bullfrog AI TherapeuticsMD Leap Therapeutics Imunon (NASDAQ:IMNN) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations. Which has preferable earnings & valuation, IMNN or SHPH? Shuttle Pharmaceuticals has lower revenue, but higher earnings than Imunon. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Imunon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImunon$500K28.13-$18.62M-$12.95-0.45Shuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.84 Which has more volatility & risk, IMNN or SHPH? Imunon has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.08, suggesting that its stock price is 208% less volatile than the S&P 500. Do insiders and institutionals believe in IMNN or SHPH? 4.5% of Imunon shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 6.0% of Imunon shares are held by insiders. Comparatively, 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is IMNN or SHPH more profitable? Imunon's return on equity of -405.07% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ImunonN/A -405.07% -158.41% Shuttle Pharmaceuticals N/A -772.76%-347.06% Do analysts rate IMNN or SHPH? Imunon presently has a consensus price target of $232.50, suggesting a potential upside of 3,932.96%. Given Imunon's stronger consensus rating and higher possible upside, analysts clearly believe Imunon is more favorable than Shuttle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Imunon 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75Shuttle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor IMNN or SHPH? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than Imunon. MarketBeat recorded 4 mentions for Shuttle Pharmaceuticals and 3 mentions for Imunon. Imunon's average media sentiment score of 0.95 beat Shuttle Pharmaceuticals' score of 0.44 indicating that Imunon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Imunon 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shuttle Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryImunon beats Shuttle Pharmaceuticals on 10 of the 15 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.73M$2.55B$5.80B$10.10BDividend YieldN/A48.62%5.25%4.56%P/E Ratio-0.8423.7975.8126.14Price / SalesN/A674.56536.55119.56Price / CashN/A169.9337.4259.95Price / Book0.805.3311.756.24Net Income-$9.15M$32.95M$3.29B$270.65M7 Day Performance2.35%3.03%1.57%3.48%1 Month Performance1.45%10.90%8.46%7.86%1 Year Performance-90.31%0.80%63.87%27.53% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.9878 of 5 stars$3.49+1.2%N/A-90.5%$3.73MN/A-0.845Short Interest ↓Gap DownIMNNImunon2.0547 of 5 stars$5.85-1.3%$232.50+3,874.4%-66.1%$14.27MN/A-0.4530Short Interest ↓NRSNNeuroSense Therapeutics2.8881 of 5 stars$1.04-1.9%$14.00+1,246.2%+17.2%$14.21MN/A-1.9310News CoverageGap DownPRPHProPhase Labs1.4575 of 5 stars$0.33-2.3%N/A-82.2%$13.72M$6.77M-0.26130Positive NewsShort Interest ↓NXTCNextCure4.6619 of 5 stars$4.99-0.8%$25.50+411.0%-66.1%$13.37MN/A-0.1990Gap DownSNGXSoligenix2.2969 of 5 stars$3.11+0.3%$6.00+92.9%-21.5%$13.33MN/A-0.8220Short Interest ↓FLGCFlora Growth3.1421 of 5 stars$22.71+11.1%$93.00+309.5%-41.4%$13.15M$52.37M-0.66280Positive NewsShort Interest ↓Gap UpHigh Trading VolumeLGVNLongeveron2.9136 of 5 stars$0.82-0.7%$7.67+832.8%-60.8%$12.48M$2.07M-0.1320BFRGBullfrog AI0.8631 of 5 stars$1.22+0.8%N/A-48.8%$12.30M$60K-1.614TXMDTherapeuticsMD0.7187 of 5 stars$1.06-4.5%N/A-38.2%$12.26M$1.76M0.00420Positive NewsLPTXLeap Therapeutics1.8632 of 5 stars$0.29+2.1%$3.38+1,046.0%-90.0%$12.20MN/A-0.1940Positive News Related Companies and Tools Related Companies IMNN Alternatives NRSN Alternatives PRPH Alternatives NXTC Alternatives SNGX Alternatives FLGC Alternatives LGVN Alternatives BFRG Alternatives TXMD Alternatives LPTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
